Analyst Ratings for Meridian Biosciences (VIVO) [Buys]

VIVO Rating Summary

VIVO Price Target Summary

  |   Expand Research on VIVO
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $19.80 (-10.4%)
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
4/12/2013 Sidoti New Coverage Buy
(N/A)
28.00
(N/A)
22.07 22.10 0.14% Details
10/2/2012 Cowen New Coverage Outperform
(N/A)
N/A
(N/A)
18.95 22.10 16.62% Details
7/7/2011 Lazard Capital Upgrade Buy
(N/A)
N/A
(N/A)
24.73 22.10 -10.63% Details
Like VIVO Ratings? Also take a look at ALR

VIVO Ratings News